Long COVID
Outcome unclear
Long COVID: microdosing a no-go after MCAS flares and angioedema
- Condition
- Long COVID
- At worst
- Not stated
- Ill for
- Not stated
- Last post
- Nov 2025
In their words
- Condition: Long COVID
It was a no-go for me.
In context ↗
Read from 1 of their posts and comments; links to the one this page draws on
Summary
Crocus 26883, a Reddit user in a long-COVID community, reported in a November 2025 comment that microdosing was a no-go for them: the first two microdoses caused MCAS flares with angioedema. They called the attempt a big waste of money.
Ask Miruvor AI
What they tried
Also tried
Their words about each treatment
- GLP-1 · Worse
It was a no-go for me. The first two microdoses caused MCAS flares with angioedema. Big waste of money
In context ↗
Adverse events
- GLP-1 drugs (unspecified)“The first two microdoses caused MCAS flares with angioedema.” In context ↗ Autoimmune or inflammatory flare
Symptoms mentioned
Their words about their symptoms
- Mast cell (MCAS) & allergies
The first two microdoses caused MCAS flares with angioedema
In context ↗